The report provides industry landscape, competitive landscape and industry trends information on the facial aesthetics, breast implants and body contouring industry categories. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the industry dynamics. The report reviews the competitive landscape in terms of mergers and take over s, pipeline products and technology offerings.

Scope of the Research

- The report covers data and analysis on the aesthetic devices industry in the leading geographies of the world comprising of the United States, Canada, Germany, France, Italy, Spain and Japan.
- The report covers global industry size and industry player share data for three surgical equipment industry categories categories – Aesthetic Lasers and Energy Devices, Facial Aesthetics and Breast Implants.
- Annualized industry revenues data from 2001 to 2008, projection forward for 7 years to 2015.
- The report provides qualitative analysis of industry drivers, restraints, future outlook and challenges by categories and sectors .
- The report also covers information on the leading industry players, the competitive landscape, and the leading pipeline products and technologies.
- Key topics covered include the global aesthetic devices Merger and Acquisition landscape and opportunity analysis of the emerging industry s.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Industry s Direct’s team of market experts.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the aesthetic devices industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop industry -entry and industry expansion strategies.
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the aesthetic devices industry landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global aesthetic devices industry and the factors shaping it.

Table Of Contents



Table Of Contents


1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 12
2.1 Executive Summary 12
3 The Future of the Aesthetic Devices March ket to 2015 14
3.1 Overview 14
3.2 Impact of Economic Downturn on Aesthetic Devices March ket 17
3.3 Aesthetic Devices March ket Drivers 18
3.3.1 Demographics 18
3.3.2 Aesthetic Devices Safe and Effective Approach 18
3.3.3 Expanding Non Core Physicians Base 18
3.3.4 Direct to Consumer Approach 18
3.3.5 Innovation 18
3.4 March ket Restraints 19
4 Aesthetic Lasers and Energy Devices 20
4.1 March ket Size 20
4.1.1 Skin Rejuvenation, Skin Tightening and Cellulite Reduction 22
4.1.2 Hair Removal 22
4.1.3 Vascular and Pigmented Lesions 23
4.1.4 Tattoo Removal 23
4.2 Competitive Landscape 24
5 Breast Implants 26
5.1 March ket Size 26
5.2 Competitive Landscape 27
5.3 Saline Breast Implants 29
5.4 Silicone Breast Implants 30
6 Facial Aesthetics 33
6.1 March ket Size 33
6.2 Competitive Landscape 34
6.3 Hyaluronic Acid 35
6.4 Particle and Polymer Fillers (PPF) 37
6.5 Collagen Products 39
7 Aesthetic Devices March ket: Merger and Acquisition Landscape 41
7.1 Thermage Takes Over Reliant Technologies 42
7.1.1 Key Facts 42
7.1.2 Deal in Brief 42
7.1.3 Deal Rationale 43
7.1.4 Detailed Target Information 43
7.1.5 Detailed Acquirer Information 43
7.2 Johnson and Johnson Takes Over Mentor 44
7.2.1 Key Facts 44
7.2.2 Deal in Brief 44
7.2.3 Deal Rationale 45
7.2.4 Detailed Target Information 45
7.2.5 Detailed Acquirer Information 46
7.3 Syneron Medical to Acquire Inlight 47
7.3.1 Key Facts 47
7.3.2 Deal in Brief 47
7.3.3 Deal Rationale 47
7.3.4 Detailed Target Information 48
7.3.5 Detailed Acquirer Information 48
7.4 Applisonix Takes Over CureLight Medical 49
7.4.1 Key Facts 49
7.4.2 Deal in Brief 49
7.4.3 Deal Rationale 49
7.4.4 Detailed Target Information 50
7.4.5 Detailed Acquirer Information 50
7.5 PhotoMedex Takes Over Photo Therapeutics 51
7.5.1 Key Facts 51
7.5.2 Deal in Brief 51
7.5.3 Deal Rationale 52
7.5.4 Detailed Target Information 52
7.5.5 Detailed Acquirer Information 52
7.6 ULURU to Acquire Bio Med Sciences 53
7.6.1 Key Facts 53
7.6.2 Deal in Brief 53
7.6.3 Deal Rationale 53
7.6.4 Detailed Target Information 54
7.6.5 Detailed Acquirer Information 54
7.7 Medicis Pharmaceutical Takes Over LipoSonix 55
7.7.1 Key Facts 55
7.7.2 Deal in Brief 55
7.7.3 Deal Rationale 55
7.7.4 Detailed Target Information 56
7.7.5 Detailed Acquirer Information 56
7.8 BioForm Medical Takes Over Advanced Cosmetic Intervention 57
7.8.1 Key Facts 57
7.8.2 Deal in Brief 57
7.8.3 Deal Rationale 57
7.8.4 Detailed Target Information 58
7.8.5 Detailed Acquirer Information 58
7.9 Syneron Medical Invests In Rakuto Bio Technologies 59
7.9.1 Key Facts 59
7.9.2 Deal in Brief 59
7.9.3 Deal Rationale 59
7.9.4 Detailed Target Information 60
7.9.5 Detailed Acquirer Information 60
8 Aesthetic Devices: Pipeline Products and Technology 61
8.1 SeriGel 61
8.1.1 Product Status 61
8.1.2 Product Description 61
8.2 Mediostar Effect 62
8.2.1 Product Status 62
8.2.2 Product Description 62
8.2.3 Mediostar Effect Clinical Trials 1 63
8.2.4 Mediostar Effect Clinical Trials 2 63
8.2.5 Mediostar Effect Clinical Trials 3 64
8.2.6 Mediostar Effect Clinical Trials 4 64
8.2.7 Mediostar Effect Clinical Trials 5 64
8.2.8 Mediostar Effect Clinical Trials 6 65
8.2.9 Mediostar Effect Clinical Trials 7 65
8.3 Dermablate Effect 66
8.3.1 Product Status 66
8.3.2 Product Description 66
8.3.3 Dermablate Effect Clinical Trials 1 67
8.3.4 Dermablate Effect Clinical Trials 2 67
8.3.5 Dermablate Effect Clinical Trials 3 68
8.3.6 Dermablate Effect Clinical Trials 4 68
8.4 Tattoo Star Effect 69
8.4.1 Product Status 69
8.4.2 Product Description 69
8.4.3 TattooStar Effect Clinical Trials 1 70
8.4.4 TattooStar Effect Clinical Trials 2 70
8.5 Ultrasound device 71
8.5.1 Product Status 71
8.5.2 Product Description 71
8.6 Contour Plus 72
8.6.1 Product Status 72
8.6.2 Product Description 72
8.6.3 Contour Plus Clinical Trials 1 72
8.6.4 Contour Plus Clinical Trials 2 73
8.6.5 Contour Plus Clinical Trials 3 73
8.6.6 Contour Plus Clinical Trials 4 73
8.7 Haptized Collagen Tissue August mentation 74
8.7.1 Product Status 74
8.7.2 Product Description 74
8.8 LipoSonix Technology 75
8.8.1 Product Status 75
8.8.2 Product Description 75
8.8.3 LipoSonix Technology Clinical Trials 1 75
8.8.4 LipoSonix Technology Clinical Trials 2 76
8.8.5 LipoSonix Technology Clinical Trials 3 76
8.8.6 LipoSonix Technology Clinical Trials 4 77
8.9 Isolagen Therapy 78
8.9.1 Product Status 78
8.9.2 Product Description 78
8.9.3 Isolagen Therapy Clinical Trials 1 78
8.9.4 Isolagen Therapy Clinical Trials 2 79
8.9.5 Isolagen Therapy Clinical Trials 3 80
8.9.6 Isolagen Therapy Clinical Trials 4 81
8.9.7 Isolagen Therapy Clinical Trials 5 82
8.9.8 Isolagen Therapy Clinical Trials 6 83
8.10 Dermal Bead 84
8.10.1 Product Status 84
8.10.2 Product Description 84
8.10.3 Clinical Trials 84
8.11 VOLUMA 85
8.11.1 Product Status 85
8.11.2 Product Description 85
8.12 Plasma Skin Regeneration 86
8.12.1 Product Status 86
8.12.2 Product Description 86
9 Global Aesthetic Devices Clinical Trial Summary 87
10 Future Outlook 90
11 Definitions 91
11.1 Aesthetic Lasers and Energy Devices 91
11.2 Breast Implants 91
11.2.1 Saline 91
11.2.2 Silicone 91
11.3 Facial Aesthetics 91
11.3.1 Hyaluronic Acid 91
11.3.2 Particle and Polymer Fillers 91
11.3.3 Collagen Products 91
12 Appendix 92
12.1 Methodology 92
12.1.1 Coverage 93
12.1.2 Secondary Research 93
12.1.3 Primary Research 93
12.1.4 Models 94
12.1.5 Projections 94
12.1.6 Expert Panels 94
12.2 Sources 95
12.3 Abbreviations 95
12.4 Contact Us 95
12.5 Disclaimer 95


List of Tables


Table 1: Aesthetic Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 15
Table 2: Aesthetic Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 16
Table 3: Aesthetic Lasers and Energy Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 21
Table 4: Breast Implants March ket, Global, Overall Revenue ($ mn), 2008 - 2015 27
Table 5: Saline Breast Implants March ket, Global, Overall Revenue ($ m), 2008 - 2015 30
Table 6: Silicone Breast Implants March ket, Global, Overall Revenue ($ m), 2008 - 2015 32
Table 7: Facial Aesthetics March ket, Global, Overall Revenue ($ m), 2008 - 2015 34
Table 8: Hyaluronic Acid March ket, Global, Overall Revenue ($ m), 2008 - 2015 36
Table 9: Particle and Polymer Fillers March ket, Global, Overall Revenue ($ m), 2008 - 2015 38
Table 10: Collagen Products March ket, Global, Overall Revenue ($ m), 2008 - 2015 40
Table 11: Aesthetic Devices, Major Merger and Acquisition s, 2008 41
Table 12: Thermage Takes Over Reliant Technologies, Key Facts 42
Table 13: Reliant Technologies, Inc., Key Facts 43
Table 14: Thermage, Inc., Key Facts 43
Table 15: Johnson and Johnson Takes Over Mentor, Key Facts 44
Table 16: Mentor Corporation, Key Facts 45
Table 17: Mentor Corporation, Share Price Information 45
Table 18: Mentor Corporation, Firms Valuation Multiples 46
Table 19: Johnson and Johnson, Key Facts 46
Table 20: Syneron Medical To Take Over Inlight, Key Facts 47
Table 21: Inlight Corp., Key Facts 48
Table 22: Syneron Medical Ltd., Key Facts 48
Table 23: Applisonix Takes Over CureLight Medical, Key Facts 49
Table 24: CureLight Medical Ltd., Key Facts 50
Table 25: Applisonix Ltd., Key Facts 50
Table 26: PhotoMedex Takes Over Photo Therapeutics, Key Facts 51
Table 27: Photo Therapeutics Limited, Key Facts 52
Table 28: PhotoMedex, Inc., Key Facts 52
Table 29: ULURU To Take Over Bio Med Sciences, Key Facts 53
Table 30: Bio Med Sciences, Inc., Key Facts 54
Table 31: ULURU, Inc., Key Facts 54
Table 32: Medicis Pharmaceutical Takes Over LipoSonix, Key Facts 55
Table 33: LipoSonix, Inc., Key Facts 56
Table 34: Medicis Pharmaceutical Corporation, Key Facts 56
Table 35: BioForm Medical Takes Over Advanced Cosmetic Intervention, Key Facts 57
Table 36: Advanced Cosmetic Intervention, Inc., Key Facts 58
Table 37: BioForm Medical, Inc., Key Facts 58
Table 38: Syneron Medical Invests In Rakuto Bio Technologies, Key Facts 59
Table 39: Rakuto Bio Technologies Ltd., Key Facts 60
Table 40: Syneron Medical Ltd., Key Facts 60
Table 41: SeriGel, Product Status 61
Table 42: SeriGel, Product Description 61
Table 43: Mediostar Effect, Product Status 62
Table 44: Mediostar Effect, Product Description 62
Table 45: Mediostar Effect Clinical Trials 1 63
Table 46: Mediostar Effect Clinical Trials 2 63
Table 47: Mediostar Effect Clinical Trials 3 64
Table 48: Mediostar Effect Clinical Trials 4 64
Table 49: Mediostar Effect Clinical Trials 5 64
Table 50: Mediostar Effect Clinical Trials 6 65
Table 51: Mediostar Effect Clinical Trials 7 65
Table 52: Dermablate Effect, Product Status 66
Table 53: Dermablate Effect, Product Description 66
Table 54: Dermablate Effect Clinical Trials 1 67
Table 55: Dermablate Effect Clinical Trials 2 67
Table 56: Dermablate Effect Clinical Trials 3 68
Table 57: Dermablate Effect Clinical Trials 4 68
Table 58: TattooStar Effect, Product Status 69
Table 59: TattooStar Effect, Product Description 69
Table 60: TattooStar Effect Clinical Trials 1 70
Table 61: TattooStar Effect Clinical Trials 2 70
Table 62: Ultrasound device, Product Status 71
Table 63: Ultrasound device, Product Description 71
Table 64: Contour Plus, Product Status 72
Table 65: Contour Plus, Product Description 72
Table 66: Contour Plus Clinical Trials 1 72
Table 67: Contour Plus Clinical Trials 2 73
Table 68: Contour Plus Clinical Trials 3 73
Table 69: Contour Plus Clinical Trials 4 73
Table 70: Haptized Collagen Tissue August mentation, Product Status 74
Table 71: Haptized Collagen Tissue August mentation, Product Description 74
Table 72: LipoSonix Technology, Product Status 75
Table 73: LipoSonix Technology, Product Description 75
Table 74: LipoSonix Technology Clinical Trials 1 75
Table 75: LipoSonix Technology Clinical Trials 2 76
Table 76: LipoSonix Technology Clinical Trials 3 76
Table 77: LipoSonix Technology Clinical Trials 4 77
Table 78: Isolagen Therapy, Product Status 78
Table 79: Isolagen Therapy, Product Status 78
Table 80: Isolagen Therapy Clinical Trials 1 78
Table 81: Isolagen Therapy Clinical Trials 2 79
Table 82: Isolagen Therapy Clinical Trials 3 80
Table 83: Isolagen Therapy Clinical Trials 4 81
Table 84: Isolagen Therapy Clinical Trials 5 82
Table 85: Isolagen Therapy Clinical Trials 6 83
Table 86: Dermal Bead, Product Status 84
Table 87: Dermal Bead, Product Description 84
Table 88: Dermal Bead Clinical Trials 1 84
Table 89: VOLUMA, Product Status 85
Table 90: VOLUMA, Product Description 85
Table 91: Plasma Skin Regeneration, Product Status 86
Table 92: Plasma Skin Regeneration, Product Description 86
Table 93: Global Aesthetic Devices, Clinical Trial Summary 87


1.2 List of Figures


Figure 1: Aesthetic Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 14
Figure 2: Aesthetic Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 15
Figure 3: Aesthetic Lasers and Energy Devices March ket, Global, Overall Revenue ($ m), 2008 - 2015 21
Figure 4: Aesthetic Lasers and Energy Devices March ket, US, Firms Share (%), 2008 24
Figure 5: Aesthetic Lasers and Energy Devices March ket, Europe, Firms Share (%), 2008 25
Figure 6: Breast Implants March ket, Global, Overall Revenue ($ m), 2008 - 2015 26
Figure 7: Breast Implants March ket, US, Firms Share (%), 2008 28
Figure 8: Breast Implants March ket, Europe, Firms Share (%), 2008 28
Figure 9: Saline Breast Implants March ket, Global, Overall Revenue ($ m), 2008 - 2015 29
Figure 10: Silicone Breast Implants March ket, Global, Overall Revenue ($ m), 2008 - 2015 31
Figure 11: Facial Aesthetics March ket, Global, Overall Revenue ($ m), 2008 - 2015 33
Figure 12: Facial Aesthetics March ket, US, Firms Share (%), 2008 34
Figure 13: Facial Aesthetics March ket, Europe, Firms Share (%), 2008 35
Figure 14: Hyaluronic Acid March ket, Global, Overall Revenue ($ m), 2008 - 2015 36
Figure 15: Particle and Polymer Fillers March ket, Global, Overall Revenue ($ m), 2008 - 2015 37
Figure 16: Collagen Products March ket, Global, Overall Revenue ($ m), 2008 - 2015 39
Figure 17: Global March kets Direct Methodology 92

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.